Ország: Ausztrália
Nyelv: angol
Forrás: Department of Health (Therapeutic Goods Administration)
paracetamol, Quantity: 500 mg; codeine phosphate hemihydrate, Quantity: 6 mg; phenylephrine hydrochloride, Quantity: 5 mg
Cipla Australia Pty Ltd
codeine phosphate hemihydrate,Paracetamol,Phenylephrine hydrochloride
Tablet, uncoated
Excipient Ingredients: purified water; magnesium stearate; microcrystalline cellulose; maize starch; colloidal anhydrous silica; hyprolose; povidone
Oral
12, 36, 24
(S4) Prescription Only Medicine
Temporary symptomatic relief of headache, myalgia, fever, nasal congestion and rhinorrhoea in patients aged 12 years and older.
Visual Identification: White to off white circular, flat, bevelled edge uncoated tablet, breakline on one side and plain on other side.; Container Type: Blister Pack; Container Material: PVC/PVDC/PE; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Licence status A
2014-01-22